A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in

Clinical Trial Description

This will be a randomized, open-label and active-control study to assess the PK, PD and safety profiles of LY01005 versus goserelin comparator to be conducted in the USA. ;

Study Design

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT05191017` - Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC	Phase 1/Phase 2
Completed	`NCT00970203` - Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer	Phase 2
Completed	`NCT03031418` - Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI)
Completed	`NCT01639859` - Assessment of Supersonic Imagine Aixplorer for the Detection and Localisation of Prostate Cancer Foci	N/A
Not yet recruiting	`NCT06406803` - The Impact of Physical Activity Versus Dietary Energy Restriction on Tumour and Muscle Protein Synthesis in Prostate Cancer Patients	N/A
Completed	`NCT02362464` - Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139	Phase 2
Enrolling by invitation	`NCT05844761` - Real-time Motion Management During Prostate and Lung Radiotherapy	N/A
Completed	`NCT03442075` - Pain Comparison Whit Visual Analog Scale (EVA) Between Four Analgesic Methods During Trans Rectal Prostatic Biopsy
Recruiting	`NCT05252390` - NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors	Phase 1/Phase 2
Recruiting	`NCT03896958` - The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
Completed	`NCT03444532` - Feasibility Study Testing a Sleep Intervention in Prostate Cancer Patients With Insomnia	N/A
Recruiting	`NCT05600400` - Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate Cancer	N/A
Recruiting	`NCT04887935` - Neoadjuvant SGLT2 Inhibition in High-Risk Localized Prostate Cancer	Phase 1
Completed	`NCT02235142` - Prostatic Cancer Versus Androgen Deficiency	N/A
Recruiting	`NCT06318559` - Artificial Intelligence 3D Augmented Reality Robot-Assisted-Radical- Prostatectomy v.s. no3D Intervention	N/A
Completed	`NCT01477749` - Sipuleucel-T Manufacturing Demonstration Study	Phase 2
Active, not recruiting	`NCT03632980` - Dynamic Focusing Evaluation for Prostate Cancer Treatment	N/A
Recruiting	`NCT04319783` - Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA	Phase 2
Recruiting	`NCT04258813` - Onco-primary Care Networking to Support TEAM-based Care	N/A
Recruiting	`NCT05361798` - T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine M9241 in Localized High- and Intermediate-Risk Prostate Cancer Treated With Androgen Deprivation Therapy	Phase 2

NCT number	NCT03450109
Study type	Interventional
Source	Luye Pharma Group Ltd.
Contact
Status	Completed
Phase	Phase 1
Start date	December 22, 2017
Completion date	October 30, 2018

A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in Patients With Prostate Cancer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms